18 of 26 for:
"Vulvovaginal Candidiasis" | "Hormone Antagonists" A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute
Vaginal Candidiasis (Yeast Infection)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
disclaimer for details.
ClinicalTrials.gov Identifier: NCT01891331
First Posted : July 3, 2013
Results First Posted : July 6, 2018
Last Update Posted : August 1, 2018
Information provided by (Responsible Party):
Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Triple (Participant, Care Provider, Investigator); Primary Purpose: Treatment
Principal Investigators are NOT employed by the organization sponsoring the study.
There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts
the PI's rights to discuss or publish trial results after the trial is completed.
Neither institution nor principal investigator shall publish the results of the trial without prior written consent of the sponsor, which it may withhold in its sole discretion.
Layout table for Results Point of Contact information
Viamet Pharmaceuticals Inc
Layout table for additonal information
History of Changes
Other Study ID Numbers:
June 17, 2013
July 3, 2013
Results First Submitted:
June 6, 2018
Results First Posted:
July 6, 2018
Last Update Posted:
August 1, 2018